Abstract:[Objective] To investigate the clinical outcomes of debridement, antibiotics, and implant retention (DAIR) for periprosthetic joint infection (PJI) after primary total knee arthroplasty (TKA). [Methods] A retrospective study was conducted on 33 patients who received DAIR for PJI in our hospital from January 2016 to June 2020, including 28 patients suffered from PJI within 3 months after TKA, and 5 pa- tients in 4~6 months after surgery. The clinical and laboratory results were evaluated. [Results] All patients had DAIR performed successful- ly with operation time of (113.5±12.4) min, and intraoperative blood loss of (43.5±7.4) ml, and were followed up for (44.1±11.7) months. Of them, 28 cases were successful with the success rate of 84.8%, whereas 5 cases were of surgical failure, including 2 cases infected within 3 months after the initial replacement, 3 cases infected in 4 to 6 months after the operation, with the failure rate of 15.2%. Compared with those before DAIR, the VAS score for pain [(5.1±1.4), (1.4±0.9), P<0.001] significantly reduced, while the KSS functional score [(43.0±9.9), (81.8± 11.3), P<0.001] and KSS clinical score [(37.8±14.9), (84.0±7.0), P<0.001] significantly increased at the latest follow-up. In term of lab test, bacterial culture were negative in 15 cases (45.5%), whereas positive in 18 cases (54.5%). The WBC, CRP and ESR were significantly de- creased over time (P<0.05). [Conclusion] The DAIR does achieve satisfactory early clinical consequences for PJI. However, its failure rate for PJI in 4 to 6 months after primary TKA is relatively higher than that within 3 months after the surgery.